MOESM3 of Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

Name: MOESM3 of Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
Creator: You, Hua; Xu-Monette, Zijun; Tzankov, Alexandar; Hsi, Eric; Møller, Michael; Kirsch, Ilan; Manyam, Ganiraju; Piris, Miguel; Young, Ken; Dybkaer, Karen; Xia, Yi; Medeiros, Jeffrey; Li, Jianyong; Ferreri, Andrés; Xu, Bing; Miao, Yi; Winter, Jane; Snyder, Thomas; Xiao, Min; Bremel, Robert; Li, Yong; Huh, Jooryung; Tam, Wayne; Krieken, J.; Zhang, Hongwei; Tan, Xiaohong; Ponzoni, Maurilio; Bhagat, Govind; Visco, Carlo; Crossley, Beryl
Published: 2019-11-13T00:00:00+08:00